La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells.

Identifieur interne : 001E31 ( Main/Exploration ); précédent : 001E30; suivant : 001E32

Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells.

Auteurs : Sadayuki Hashioka ; Andis Klegeris ; Claudia Schwab ; Patrick L. Mcgeer

Source :

RBID : pubmed:18375019

English descriptors

Abstract

Astrocytes and microglia become activated in a broad spectrum of inflammatory neurodegenerative diseases. Activated microglia are widely believed to be the principal source of inflammation-induced neuronal degeneration in these disorders. To investigate the neurotoxic potential of human astrocytes, we exposed them and human astrocytic U-373 MG cells to a variety of inflammatory stimulants. We then assessed the effects of their supernatants on human SH-SY5 cells. When astrocytes and U-373 MG cells were stimulated with interferon (IFN)-gamma (150U/ml), their supernatants significantly reduced SH-SY5Y cell viability. Other powerful inflammatory stimulants such as lipopolysaccharide (0.5mug/ml), tumor necrosis factor-alpha (10ng/ml) and interleukin-1beta (10ng/ml), alone or in combination, were without effect. These combinations were also unable to enhance the IFN-gamma effect. The induced cytotoxicities were reversed by JAK inhibitor I, a potent and specific inhibitor of JAKs. This result indicates that the neurotoxic effect was proceeding through the IFN-gamma receptor (IFNGR)-JAK-STAT intracellular pathway. To establish that the IFNGR is expressed on both cultured astrocytes and U-373 MG cells, we performed RT-PCR on total RNA extracts to identify a specific IFNGR product. We showed the protein product on these cultured cells by immunocytochemistry using an antibody to IFNGR. Finally, using human postmortem material, we showed sharp upregulation of the IFNGR on activated astrocytes in affected areas in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis. These findings suggest that activated astrocytes may become neurotoxic when stimulated by IFN-gamma and may therefore exacerbate the pathology in a spectrum of neurodegenerative diseases.

DOI: 10.1016/j.neurobiolaging.2008.02.019
PubMed: 18375019


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells.</title>
<author>
<name sortKey="Hashioka, Sadayuki" sort="Hashioka, Sadayuki" uniqKey="Hashioka S" first="Sadayuki" last="Hashioka">Sadayuki Hashioka</name>
<affiliation>
<nlm:affiliation>Kinsmen Laboratory of Neurological Research, Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 1W5 Canada.</nlm:affiliation>
<wicri:noCountry code="subField">V6T 1W5 Canada</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Klegeris, Andis" sort="Klegeris, Andis" uniqKey="Klegeris A" first="Andis" last="Klegeris">Andis Klegeris</name>
</author>
<author>
<name sortKey="Schwab, Claudia" sort="Schwab, Claudia" uniqKey="Schwab C" first="Claudia" last="Schwab">Claudia Schwab</name>
</author>
<author>
<name sortKey="Mcgeer, Patrick L" sort="Mcgeer, Patrick L" uniqKey="Mcgeer P" first="Patrick L" last="Mcgeer">Patrick L. Mcgeer</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:18375019</idno>
<idno type="pmid">18375019</idno>
<idno type="doi">10.1016/j.neurobiolaging.2008.02.019</idno>
<idno type="wicri:Area/PubMed/Corpus">000E09</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E09</idno>
<idno type="wicri:Area/PubMed/Curation">000E09</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E09</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000E09</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000E09</idno>
<idno type="wicri:Area/Ncbi/Merge">000896</idno>
<idno type="wicri:Area/Ncbi/Curation">000896</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000896</idno>
<idno type="wicri:Area/Main/Merge">001F81</idno>
<idno type="wicri:Area/Main/Curation">001E31</idno>
<idno type="wicri:Area/Main/Exploration">001E31</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells.</title>
<author>
<name sortKey="Hashioka, Sadayuki" sort="Hashioka, Sadayuki" uniqKey="Hashioka S" first="Sadayuki" last="Hashioka">Sadayuki Hashioka</name>
<affiliation>
<nlm:affiliation>Kinsmen Laboratory of Neurological Research, Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 1W5 Canada.</nlm:affiliation>
<wicri:noCountry code="subField">V6T 1W5 Canada</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Klegeris, Andis" sort="Klegeris, Andis" uniqKey="Klegeris A" first="Andis" last="Klegeris">Andis Klegeris</name>
</author>
<author>
<name sortKey="Schwab, Claudia" sort="Schwab, Claudia" uniqKey="Schwab C" first="Claudia" last="Schwab">Claudia Schwab</name>
</author>
<author>
<name sortKey="Mcgeer, Patrick L" sort="Mcgeer, Patrick L" uniqKey="Mcgeer P" first="Patrick L" last="Mcgeer">Patrick L. Mcgeer</name>
</author>
</analytic>
<series>
<title level="j">Neurobiology of aging</title>
<idno type="eISSN">1558-1497</idno>
<imprint>
<date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Alzheimer Disease (metabolism)</term>
<term>Amyotrophic Lateral Sclerosis (metabolism)</term>
<term>Astrocytes (immunology)</term>
<term>Astrocytes (physiology)</term>
<term>Astrocytoma (immunology)</term>
<term>Astrocytoma (physiopathology)</term>
<term>Brain (immunology)</term>
<term>Brain (physiopathology)</term>
<term>Cell Line, Tumor</term>
<term>Cell Survival</term>
<term>Humans</term>
<term>Interferon-gamma (metabolism)</term>
<term>Janus Kinases (antagonists & inhibitors)</term>
<term>Janus Kinases (metabolism)</term>
<term>Lipopolysaccharides (metabolism)</term>
<term>Multiple Sclerosis (metabolism)</term>
<term>Parkinson Disease (metabolism)</term>
<term>Receptors, Interferon (metabolism)</term>
<term>Signal Transduction</term>
<term>Tumor Necrosis Factor-alpha (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Janus Kinases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Interferon-gamma</term>
<term>Janus Kinases</term>
<term>Lipopolysaccharides</term>
<term>Receptors, Interferon</term>
<term>Tumor Necrosis Factor-alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Astrocytes</term>
<term>Astrocytoma</term>
<term>Brain</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Alzheimer Disease</term>
<term>Amyotrophic Lateral Sclerosis</term>
<term>Multiple Sclerosis</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Astrocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Astrocytoma</term>
<term>Brain</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Cell Line, Tumor</term>
<term>Cell Survival</term>
<term>Humans</term>
<term>Signal Transduction</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Astrocytes and microglia become activated in a broad spectrum of inflammatory neurodegenerative diseases. Activated microglia are widely believed to be the principal source of inflammation-induced neuronal degeneration in these disorders. To investigate the neurotoxic potential of human astrocytes, we exposed them and human astrocytic U-373 MG cells to a variety of inflammatory stimulants. We then assessed the effects of their supernatants on human SH-SY5 cells. When astrocytes and U-373 MG cells were stimulated with interferon (IFN)-gamma (150U/ml), their supernatants significantly reduced SH-SY5Y cell viability. Other powerful inflammatory stimulants such as lipopolysaccharide (0.5mug/ml), tumor necrosis factor-alpha (10ng/ml) and interleukin-1beta (10ng/ml), alone or in combination, were without effect. These combinations were also unable to enhance the IFN-gamma effect. The induced cytotoxicities were reversed by JAK inhibitor I, a potent and specific inhibitor of JAKs. This result indicates that the neurotoxic effect was proceeding through the IFN-gamma receptor (IFNGR)-JAK-STAT intracellular pathway. To establish that the IFNGR is expressed on both cultured astrocytes and U-373 MG cells, we performed RT-PCR on total RNA extracts to identify a specific IFNGR product. We showed the protein product on these cultured cells by immunocytochemistry using an antibody to IFNGR. Finally, using human postmortem material, we showed sharp upregulation of the IFNGR on activated astrocytes in affected areas in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis. These findings suggest that activated astrocytes may become neurotoxic when stimulated by IFN-gamma and may therefore exacerbate the pathology in a spectrum of neurodegenerative diseases.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Hashioka, Sadayuki" sort="Hashioka, Sadayuki" uniqKey="Hashioka S" first="Sadayuki" last="Hashioka">Sadayuki Hashioka</name>
<name sortKey="Klegeris, Andis" sort="Klegeris, Andis" uniqKey="Klegeris A" first="Andis" last="Klegeris">Andis Klegeris</name>
<name sortKey="Mcgeer, Patrick L" sort="Mcgeer, Patrick L" uniqKey="Mcgeer P" first="Patrick L" last="Mcgeer">Patrick L. Mcgeer</name>
<name sortKey="Schwab, Claudia" sort="Schwab, Claudia" uniqKey="Schwab C" first="Claudia" last="Schwab">Claudia Schwab</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E31 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E31 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:18375019
   |texte=   Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:18375019" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022